Rchr
J-GLOBAL ID:202001017080784380   Update date: Jun. 09, 2021

Himoto Yuki

Himoto Yuki | Himoto Yuki
Affiliation and department:
Job title: 特定病院助教
Research field  (1): Radiology
Papers (26):
  • Yuki Himoto, Yulia Lakhman, Shinya Fujii, Satoshi Morita, Jennifer J Mueller, Mario M Leitao Jr, Aki Kido. Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer. Abdominal radiology (New York). 2021
  • Ryo Yajima, Aki Kido, Ryo Kuwahara, Yusaku Moribata, Yoshitsugu Chigusa, Yuki Himoto, Yasuhisa Kurata, Yuka Matsumoto, Satoshi Otani, Naoko Nishio, et al. Diagnostic performance of preoperative MR imaging findings for differentiation of uterine leiomyoma with intraligamentous growth from subserosal leiomyoma. Abdominal radiology (New York). 2021
  • Harini Veeraraghavan, Claire F Friedman, Deborah F DeLair, Josip Ninčević, Yuki Himoto, Silvio G Bruni, Giovanni Cappello, Iva Petkovska, Stephanie Nougaret, Ines Nikolovski, et al. Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers. Scientific reports. 2020. 10. 1. 17769-17769
  • Yuki Himoto, Akihiko Sakata, Mitsuhiro Kirita, Takashi Hiroi, Ken-Ichiro Kobayashi, Kenji Kubo, Hyunjin Kim, Azusa Nishimoto, Chikara Maeda, Akira Kawamura, et al. Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan. Japanese journal of radiology. 2020. 38. 5. 400-406
  • Yuki Himoto, Harini Veeraraghavan, Junting Zheng, Dmitriy Zamarin, Alexandra Snyder, Marinela Capanu, Stephanie Nougaret, Hebert A. Vargas, Fuki Shitano, Margaret Callahan, et al. Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer. JCO Precision Oncology. 2019. 3. 1-13
more...
MISC (1):
  • Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, et al. A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial). CANCER RESEARCH. 2020. 80. 4
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page